Dronabinol for the Treatment of Postoperative Pain After Arthroscopic Surgery: a Pilot Randomized Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age 18 years or older
• Patient who will undergo arthroscopic surgery of the knee including, but not limited to,
‣ Meniscectomy
⁃ Synovectomy
⁃ Chondroplasty
⁃ Loose body removal
Locations
United States
Illinois
Northwestern University Feinberg School of Medicine
RECRUITING
Chicago
Contact Information
Primary
Melissa J Shauver, MPH
melissa.shauver1@nm.org
312-472-6024
Backup
Abbie P Bennett, MS
abbie.bennett@nm.org
312-922-6024
Time Frame
Start Date: 2022-06-28
Estimated Completion Date: 2027-06
Participants
Target number of participants: 30
Treatments
Experimental: Dronabinol
Patients will received dronabinol (5mg) twice a day for 7 days in addition to standard pain medication protocol after arthroscopic knee surgery
Placebo_comparator: Placebo
Patients will received placebo twice a day for 7 days in addition to standard pain medication protocol after arthroscopic knee surgery
Related Therapeutic Areas
Sponsors
Leads: Northwestern University